Related Experiment Video
Updated: Dec 22, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Outbreak of COVID-19 infection in children: fear and serenity
P Pavone1, M Ceccarelli, R Taibi
1Section of Pediatrics and Child Neuropsychiatry, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy. gnunnari@unime.it.
Insights
Children infected with SARS-CoV-2, the virus causing COVID-19, generally experience milder illness. Current antiviral treatments show limited effectiveness in pediatric cases, necessitating further research.
Area of Science:
- Virology
- Pediatrics
- Infectious Diseases
Background:
- The SARS-CoV-2 pandemic has strained global healthcare systems, affecting all age groups.
- COVID-19 presents in three stages: mild, moderate respiratory, and severe pneumonia.
- Children typically exhibit less severe SARS-CoV-2 infections compared to adults.
Purpose of the Study:
- To review and highlight the distinct clinical manifestations of COVID-19 in children versus adults.
- To underscore the challenges in treating pediatric SARS-CoV-2 infections.
Main Methods:
- Literature review focusing on pediatric COVID-19 cases.
- Comparative analysis of clinical presentations and treatment outcomes in children and adults.
Main Results:
- SARS-CoV-2 infection demonstrates lower susceptibility and reduced severity in pediatric populations.
- Existing antiviral therapies, including interferon, lopinavir/ritonavir, orbidol, and oseltamivir, have shown insufficient efficacy in treating children with coronavirus infections.
- No specific effective antiviral drug treatments are currently available for affected children.
Conclusions:
- COVID-19 presents differently in children compared to adults, often with a more benign course.
- The lack of effective antiviral treatments for pediatric SARS-CoV-2 infections is a significant clinical concern.
- Further research is crucial to develop targeted and effective therapeutic strategies for children affected by SARS-CoV-2.
Objective:
The recent outbreak of SARS-CoV-2 greatly involves the resources of the global healthcare system, as it affects newborns, adults, and elders. This infection runs in three major stages: a mild cold-like illness, a moderate respiratory syndrome and a severe acute interstitial pneumonia. SARS-CoV-2 infection seems to have a more benign evolution in children. As a matter of fact, low susceptibility and minor aggressivity have been highlighted in most cases. There are currently no effective antiviral drugs treatment for the affected children. No sufficient results have been reached by the use of interferon (IFN), lopinavir/ritonavir, orbidol, and oseltamivir in the treatment of the coronaviruses infection. The aim of this short review is to highlight the differences existing between COVID-19 cases in adults and children.
More Related Videos
Related Concept Videos
Preparedness and Phobias
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Panic Disorder
Social Anxiety Disorder
Steps in Outbreak Investigation
Socioemotional Development during Infancy
Primary Temperament Types

